Genzyme General, Toronto Hospital deal

The partners will develop cell-based therapies to treat cardiovascular disease. The initial focus will be to develop a treatment to transplant cultured autologous cardiomyocytes (cardiac muscle cells) into scar tissue to replace damaged heart tissue following a heart attack. ...